Sunil Solomon

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sunil Solomon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
India Medicine & Life Sciences
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Drug Users Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Drug Resistance Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Risk-Taking Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Changing antibiotic resistance profile of Staphylococcus aureus isolated from HIV patients (2012–2017) in Southern India

Chinnambedu, R. S., Marimuthu, R. R., Solomon, S., Amrose, P., Ramachandran, V. & Pachamuthu, B., Jan 1 2019, (Accepted/In press) In : Journal of Infection and Public Health.

Research output: Contribution to journalArticle

Open Access
Methicillin Resistance
Microbial Drug Resistance
Staphylococcus aureus
India
HIV

Changing drug resistance profile in Pseudomonas aeruginosa infection among HIV patients from 2010–2017: A retrospective study

Swathirajan, C. R., Rameshkumar, M. R., Solomon, S., Vignesh, R. & Balakrishnan, P., Mar 1 2019, In : Journal of Global Antimicrobial Resistance. 16, p. 274-277 4 p.

Research output: Contribution to journalArticle

Pseudomonas Infections
Drug Resistance
Pseudomonas aeruginosa
Retrospective Studies
HIV

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection

Chaillon, A., Mehta, S. R., Hoenigl, M., Solomon, S., Vickerman, P., Hickman, M., Skaathun, B. & Martin, N. K., Jun 1 2019, In : PloS one. 14, 6, e0217964.

Research output: Contribution to journalArticle

Open Access
cost effectiveness
Cost effectiveness
Cost-Benefit Analysis
Antiviral Agents
India

Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset

Freiman, J. M., Wang, J., Easterbrook, P. J., Horsburgh, C. R., Marinucci, F., White, L. F., Kamkamidze, G., Krajden, M., Loarec, A., Njouom, R., Nguyen, K. V., Shiha, G., Soliman, R., Solomon, S., Tsertsvadze, T., Denkinger, C. M. & Linas, B., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Open Access
Point-of-Care Systems
Viremia
Limit of Detection
Infection
RNA

Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial

Indian National Collaboration on AIDS Study, May 1 2019, In : The Lancet HIV. 6, 5, p. e283-e296

Research output: Contribution to journalArticle

India
HIV
Population
Pharmaceutical Preparations
Therapeutics